Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT06440707
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT06440707
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06440707. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-15 (actual); primary completion 2030-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
- Acronym
- TESSERACT 2
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- High-definition Cathodal Transcranial Direct Current Stimulation (HD C-tDCS)
- Intervention (Device)
- Sham tDCS
- Lead sponsor
- University of California, Los Angeles
- Collaborator
- Johns Hopkins University
- Collaborator
- Duke University
- Collaborator
- Cedars-Sinai Medical Center
- Collaborator
- University of California, San Francisco
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
Record details
- Record id
cardio:ct-nct06440707- Content hash
f737ca0d6de8fb4f591756475eb56ac6cd232a067f37a90b00c30cf0ef513528